Our Underwriters

Print this page         

The survey on Patient Experience with Clinical Trial Materials has been made possible by the generous support of eleven underwriting companies. Their investment in the mission and work of ISPE has allowed the Patient Initiative task force to design and carry out this comprehensive project to the ultimate benefit patients around the world. ISPE wishes to thank the underwriters including:

  • Almac
  • Boehringer Ingelheim Pharma GMBH & Co.
  • Catalent Pharma Solutions
  • Cenduit LLC
  • Merck Sharp & Dohme Corporation
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • PAREXEL International
  • Pfizer Inc.
  • Takeda Development Centre Europe Ltd
  • UCB Pharma S.A.


Underwriter Logos

Last Update: 01 July 2013

My ISPE

  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile
Click to go to the Member Gift